Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Next-Generation CRISPR Promises 99 Percent Success in Treating Genetic Diseases

Next-Generation CRISPR Promises 99 Percent Success in Treating Genetic Diseases

Considered one of the century’s most important scientific advances, CRISPR-CAS9 genetic technology offers great promise, particularly for treating cancer and genetic diseases.

On 25 October 2017, two of science’s most important journals, Science and Nature , published two studies announcing methods that make CRISPR technology more precise and safer. Genetic diseases could be treated effectively with these methods.

Examining human genetic structure reveals that it consists of 6 billion nucleotides. DNAcontains 4 nucleotide types: adenine, guanine, cytosine and thymine. Because DNA is double-stranded, adenine pairs with thymine and guanine with cytosine. Incorrect pairing can occur during cell multiplication. If these errors occur during embryonic development in the womb, hereditary diseases develop. A change in a single nucleotide is called a point mutation .

In the human genome, 50.000 genetic changes associated with various diseases have been identified. Of these, 32.000 are point mutations. In the Nature study, researchers used technology called next-generation “CRISPR 2.0” to change point mutations with a %99 success rate. In other words, the faulty disease-causing nucleotide was removed, eliminating the cause. The incorrect nucleotide was thus changed without damaging DNA.

The Science study discovered a method enabling CRISPR technology to be used in RNA. As is known, CRISPR was generally used in DNA. RNA transports genetic information from DNA and makes it functional. The principal advantage of gene editing in RNA is that it does not permanently change an individual’s genetic structure. This study shows that CRISPR can also correct point mutations in RNA. The approach is particularly promising for treating blood disorders, neurological disorders, hereditary deafness and visual impairments.

What Do These Studies Mean for Us?

  • CRISPR-CAS9 genetic technology has become safer and more precise.
  • An important step has been taken toward treating genetic diseases caused particularly by a single nucleotide change.
  • In September, Chinese researchers successfully removed from embryos anemia-causing genetic mutations in their work.
  • It is important to emphasize that CRISPR genetic technology is presented as one of the most effective cancer treatments of the future. Cancer results from numerous epigenetic and genetic abnormalities. Genetic treatments targeting the causes of cancer therefore have significant potential. Cancer treatment is possible only through the opportunities offered by modern medicine.

What is CRISPR?

Sources

1. Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees ve ark.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nature 25 October 2017

2. David B. T. Cox, Jonathan S. Gootenberg, Omar O. Abudayyeh ve ark.
RNA editing with CRISPR-Cas13
Science 25 Oct 2017

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Next-Generation CRISPR Promises 99 Percent Success in Treating Genetic Diseases

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy